1.
Hawkes J, Guercio J, Kurup S, Li X, Lebwohl M. Expected Spesolimab Plasma Exposure following Intravenous and Subcutaneous Dosing in Patients with Generalized Pustular Psoriasis. J of Skin [Internet]. 2024Mar.18 [cited 2024Jul.22];8(2):s359. Available from: https://jofskin.org/index.php/skin/article/view/2655